Intensity Therapeutics Inc.
Organization details
- Legal name
- Intensity Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Shelton
- Headquarters state / province
- Connecticut
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- INTS
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001567264
- EIN
- 46-1488089
Board of directors
-
Daniel Donovan · DirectorSince 2023
-
Emer Leahy · DirectorSince 2023
-
Lewis H. Bender · Director · President and CEOSince 2023
-
Mark A. Goldberg · DirectorSince 2023
-
Thomas I. H. Dubin · DirectorSince 2024
Chief executives
Director election results
Annual meeting of June 16, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
95.5%
-
96.8%
Board connections
1 of this board's directors also sit on 1 other board. 1 is in the same sector.
-
Pasithea Therapeutics Corp. Same sectorvia Emer Leahy
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 30, 2026 | Talamo Joseph Officer (Chief Financial Officer) | Grant or award | +1,093 | $3.49 | $3,815 |
| Jun 30, 2026 | Wesolowski John M Officer (Principal Accounting Officer) | Grant or award | +3,688 | $3.49 | $12,871 |
| Mar 26, 2026 | Lewis H. Bender Director, Officer (President and CEO) | Grant or award | +37,749 | $6.11 | $230,646 |
| Dec 31, 2025 | Wesolowski John M Officer (Principal Accounting Officer) | Grant or award | +8,918 | $0.26 | $2,319 |
| Dec 31, 2025 | Talamo Joseph Officer (Chief Financial Officer) | Grant or award | +14,482 | $0.26 | $3,765 |
| Jun 30, 2025 | Wesolowski John M Officer (Principal Accounting Officer) | Grant or award | +69,745 | $0.26 | $18,134 |
| Jun 30, 2025 | Talamo Joseph Officer (Chief Financial Officer) | Grant or award | +14,179 | $0.26 | $3,687 |
| Jun 5, 2024 | Wesolowski John M Officer (Principal Accounting Officer) | Option exercise | +1,000 | $4.00 | $4,000 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Intensity Therapeutics Inc.
Who is the CEO of Intensity Therapeutics Inc.?
Lewis H. Bender has been Intensity Therapeutics Inc.'s President and CEO since June 2023.
How many directors are on Intensity Therapeutics Inc.'s board?
Intensity Therapeutics Inc.'s board has 5 directors: Daniel Donovan, Emer Leahy, Lewis H. Bender, Mark A. Goldberg and Thomas I. H. Dubin.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="intensity-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.